Adage Capital Partners’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-200,000
Closed -$3.46M 711
2017
Q2
$3.46M Buy
+200,000
New +$2.4M 0.01% 651
2016
Q4
Sell
-75,000
Closed -$1.84M 691
2016
Q3
$1.84M Buy
+75,000
New +$1.94M 0.01% 649
2016
Q1
Sell
-85,000
Closed -$8.64M 689
2015
Q4
$8.64M Sell
85,000
-95,000
-53% -$10.7M 0.02% 545
2015
Q3
$32.1M Buy
180,000
+130,000
+260% +$30.3M 0.09% 287
2015
Q2
$11.1M Hold
50,000
0.03% 535
2015
Q1
$9.93M Buy
+50,000
New +$8.87M 0.02% 552
2014
Q2
Sell
-100,000
Closed -$13.2M 695
2014
Q1
$13.2M Buy
+100,000
New +$13.7M 0.04% 467
2013
Q4
Sell
-100,000
Closed -$10.4M 687
2013
Q3
$10.4M Hold
100,000
0.03% 497
2013
Q2
$8.61M Buy
+100,000
New +$7.88M 0.03% 522

Other funds holding BHC

Adage Capital Partners's BHC Position: Q3 2017 in Review

Adage Capital Partners sold out of Bausch Health (BHC) in Q3 2017, closing a stake of 200,000 shares — an estimated $3.46M sold.

Adage Capital Partners first reported a position in BHC in Q2 2013 and held it in 9 quarters. The position peaked at $32.1M in Q3 2015. 289 funds tracked by Wall St. Rank hold BHC as of Q3 2017.

  • Adage Capital Partners reported no remaining Bausch Health position as of Q3 2017 after selling out during the quarter.
  • Adage Capital Partners sold 200,000 Bausch Health shares in Q3 2017, an estimated $3.46M.
  • Adage Capital Partners first reported a position in Bausch Health in Q2 2013 and held it in 9 quarters.
  • Adage Capital Partners's Bausch Health position peaked at $32.1M in Q3 2015.
  • 289 funds tracked by Wall St. Rank held Bausch Health as of Q3 2017.

Based on Adage Capital Partners's 13F filing for Q3 2017, filed 14 Nov 2017.